Organizing Committee
Muna Al-Khaifi MD, CCFP, MPH
University of Toronto and Mount Sinai Hospital
Conference Chair
Dr. Muna Al-Khaifi is a General Practitioner (GP) Oncologist at Mount Sinai Hospital in Toronto, where she serves as the Physician Lead of the Breast Diagnostic Clinic within the Department of Surgery. She is also an Onco-Menopause Specialist at the SHE-CAN (Sexual HEalth in breast CANcer) Clinic, Canada's first specialized clinic dedicated to the management of genitourinary syndrome of menopause in individuals with breast cancer. Dr. Al-Khaifi also works within the Cancer Survivorship Program at William Osler Health System, where she provides survivorship care for patients living with and beyond breast, skin, and gastrointestinal cancers.
In addition to her clinical roles at Mount Sinai, Dr. Al-Khaifi is an Assistant Professor in the Department of Family and Community Medicine at the University of Toronto. She is committed to advancing postgraduate medical education by developing innovative educational programs and fostering essential competencies such as empathy, cultural humility, and culturally safe care.
Previously, Dr. Al-Khaifi completed a Master of Public Health at the Dalla Lana School of Public Health, University of Toronto. She also founded and led the Breast Cancer Survivorship Program at Sunnybrook Health Sciences Centre, helping to establish comprehensive survivorship services for breast cancer patients.
Dr. Al-Khaifi is passionate about patient education, particularly in the field of breast cancer survivorship. She is dedicated to improving care for underserved and marginalized populations by examining how healthcare teams can better address the unique needs of women diagnosed with breast cancer. Her goal is to create healthcare environments that are culturally safe, inclusive, compassionate, and non-judgmental.
Christine Brezden-Masley MD, PhD, FRCP
University of Toronto and Mount Sinai Hospital
Dr. Christine Brezden-Masley is a practicing medical oncologist, Professor in the Department of Medicine’s Division of Medical Oncology at the University of Toronto’s Temerty Faculty of Medicine, Director of the Marvelle Koffler Breast Centre at Mount Sinai Hospital as well as the Medical Director of Cancer Program for Sinai Health System in Toronto, Canada. She is a senior scientist for the same Clinical Research Group at the Lunefeld-Tanenbaum Research Institute for Sinai Health System in Toronto, Canada.
Dr. Brezden-Masley is the founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a web-based virtual network promoting cancer clinical trials throughout the Toronto region. She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and is currently the President of the Canadian Cardio-Oncology Network. She is also on the Board of Directors of ReThink Breast Cancer, a national advocacy and support network for young women with breast cancer and My Gut Feeling, a stomach cancer support network for patients, survivors, and caregivers.
Speakers
Laila S. Agrawal MD
Norton Cancer Institute, Louisville, Kentucky
Muna Al-Khaifi MD, CCFP, MPH
University of Toronto and Mount Sinai Hospital
Conference Chair
Christine Brezden-Masley MD, PhD, FRCP
University of Toronto and Mount Sinai Hospital
Karen B. Glass MD, FRCSC, FACOG
University of Toronto and Sunnybrook Health Sciences Centre
Lisa Larkin MD, FACP, MSCP, IF
Ms.Medicine, Cincinnati, Ohio
Maryam Lustberg MD, MPH
Yale Cancer Center
Faculty Disclosure
It is the policy of the University of Toronto, Temerty Faculty of Medicine, Continuing Professional Development to ensure balance, independence, objectivity, and scientific rigor in all its individually accredited or jointly accredited educational programs.
Speakers and/or planning committee members, participating in University of Toronto accredited programs, are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains but is not limited to relationships within the last TWO (2) years with not-for-profit organizations, pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts.
It remains for the audience to determine whether the speaker’s outside interests may reflect a possible bias in either the exposition or the conclusions presented.